Patti Gravitt - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
Epidemiology

245 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Morse RM, Brown J, Ríos López EJ, Prieto BA, Kohler-Smith A, Gonzales Díaz K, Figueredo Escudero M, Lenin Del Cuadro D, Vásquez Del Aguila G, Daza Grandez H, Meza-Sánchez G, Tracy JK, Gravitt PE, Paz-Soldan VA. Challenges associated with follow-up care after implementation of an HPV screen-and-treat program with ablative therapy for cervical cancer prevention. Bmc Public Health. 24: 2121. PMID 39107728 DOI: 10.1186/s12889-024-19436-3  0.541
2024 Damgaard RK, Jenkins D, Stoler MH, de Koning M, van de Sandt M, Lycke KD, Kahlert J, Gravitt PE, Quint WGV, Steiniche T, Petersen LK, Hammer A. Human papillomavirus genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2. American Journal of Obstetrics and Gynecology. PMID 38336125 DOI: 10.1016/j.ajog.2024.01.029  0.365
2023 Morse RM, Brown J, Gage JC, Prieto BA, Jurczuk M, Matos A, Vásquez Vásquez J, Reátegui RR, Meza-Sanchez G, Córdova LAD, Gravitt PE, Tracy JK, Paz-Soldan VA. "Easy women get it": pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program. Bmc Public Health. 23: 2396. PMID 38042779 DOI: 10.1186/s12889-023-17324-w  0.563
2023 Lycke KD, Kahlert J, Petersen LK, Damgaard RK, Cheung LC, Gravitt PE, Hammer A. Untreated cervical intraepithelial neoplasia grade 2 and subsequent risk of cervical cancer: population based cohort study. Bmj (Clinical Research Ed.). 383: e075925. PMID 38030154 DOI: 10.1136/bmj-2023-075925  0.473
2023 Morse RM, Brown J, Gage JC, Prieto BA, Jurczuk M, Matos A, Vásquez JV, Reátegui RR, Meza-Sanchez G, Córdova LAD, Gravitt PE, Tracy JK, Paz-Soldan VA. "Easy women get it": Pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program. Research Square. PMID 37790338 DOI: 10.21203/rs.3.rs-3256535/v1  0.564
2023 Morse R, Brown J, López EJR, Prieto BA, Kohler-Smith A, Díaz KG, Escudero MF, Del Cuadro DL, Del Aguila GV, Grandez HD, Meza G, Tracy JK, Gravitt PE, Paz-Soldan VA, Group TPPS. Challenges associated with follow-up care after implementation of an HPV screen-and-treat program with ablative therapy for cervical cancer prevention in Iquitos, Peru: a mixed methods study. Research Square. PMID 37674724 DOI: 10.21203/rs.3.rs-3210614/v1  0.473
2023 Lycke KD, Kahlert J, Damgaard RK, Eriksen DO, Bennetsen MH, Gravitt PE, Petersen LK, Hammer A. Clinical course of cervical intraepithelial neoplasia grade 2: a population-based cohort study. American Journal of Obstetrics and Gynecology. 229: 656.e1-656.e15. PMID 37595822 DOI: 10.1016/j.ajog.2023.08.008  0.33
2023 Gilman SD, Gravitt PE, Paz-Soldán VA, Group PPS. Implementation of new technologies designed to improve cervical cancer screening and completion of care in low-resource settings: A case study from the Proyecto Precancer. Research Square. PMID 37461540 DOI: 10.21203/rs.3.rs-3093534/v1  0.347
2023 White JL, Grabowski MK, Rositch AF, Gravitt PE, Quinn TC, Tobian AAR, Patel EU. Trends in adolescent human papillomavirus vaccination and parental hesitancy in the United States. The Journal of Infectious Diseases. PMID 36869689 DOI: 10.1093/infdis/jiad055  0.33
2022 Khoo SP, Muhammad Ridzuan Tan NA, Rajasuriar R, Nasir NH, Gravitt P, Ng CW, Woo YL. Changes in genital Human Papillomavirus (HPV) prevalence among urban females a decade after the Malaysian HPV vaccination program. Plos One. 17: e0278477. PMID 36538522 DOI: 10.1371/journal.pone.0278477  0.532
2022 Woo YL, Khoo SP, Gravitt P, Hawkes D, Rajasuriar R, Saville M. The Implementation of a Primary HPV Self-Testing Cervical Screening Program in Malaysia through Program ROSE-Lessons Learnt and Moving Forward. Current Oncology (Toronto, Ont.). 29: 7379-7387. PMID 36290856 DOI: 10.3390/curroncol29100579  0.387
2022 Morse RM, Brown J, Noble HE, Ríos López EJ, Kohler-Smith A, Soto S, Del Cuadro DL, Gonzales Díaz K, Figueredo Escudero M, Vásquez Del Aguila G, Carrillo Jara LE, Silva Delgado HF, Palacios VA, Santos-Ortiz C, Gravitt PE, et al. Women's perspectives on the acceptability and feasibility of an HPV screen-and-treat approach to cervical cancer prevention in Iquitos, Peru: a qualitative study. Bmc Women's Health. 22: 414. PMID 36217187 DOI: 10.1186/s12905-022-01943-3  0.515
2022 Damgaard RK, Jenkins D, de Koning MN, Quint WG, Stoler MH, Doorbar J, Kahlert J, Gravitt PE, Steiniche T, Petersen LK, Hammer A. Performance of HPV E4 and p16 biomarkers in predicting regression of cervical intraepithelial neoplasia grade 2 (CIN2): protocol for a historical cohort study. Bmj Open. 12: e059593. PMID 35793925 DOI: 10.1136/bmjopen-2021-059593  0.582
2022 Rositch AF, Singh A, Lahrichi N, Paz-Soldan VA, Kohler-Smith A, Gravitt P, Gralla E. Planning for resilience in screening operations using discrete event simulation modeling: example of HPV testing in Peru. Implementation Science Communications. 3: 65. PMID 35715830 DOI: 10.1186/s43058-022-00302-5  0.338
2022 Hammer A, Blaakaer J, de Koning MNC, Steiniche T, Mejlgaard E, Svanholm H, Roensbo MT, Fuglsang K, Doorbar J, Andersen RH, Quint WGV, Gravitt PE. Evidence of latent HPV infection in older Danish women with a previous history of cervical dysplasia. Acta Obstetricia Et Gynecologica Scandinavica. PMID 35481603 DOI: 10.1111/aogs.14362  0.626
2022 Lycke KD, Petersen LK, Gravitt PE, Hammer A. Known Benefits and Unknown Risks of Active Surveillance of Cervical Intraepithelial Neoplasia Grade 2. Obstetrics and Gynecology. 139: 680-686. PMID 35271554 DOI: 10.1097/AOG.0000000000004705  0.4
2021 Clark EH, Gilman RH, Chiao EY, Gravitt PE. Gut Helminth Infection-Induced Immunotolerance and Consequences for Human Papillomavirus Persistence. The American Journal of Tropical Medicine and Hygiene. PMID 34280146 DOI: 10.4269/ajtmh.21-0191  0.314
2021 Clark EH, Gilman RH, Chiao EY, Gravitt PE. Gut Helminth Infection-Induced Immunotolerance and Consequences for Human Papillomavirus Persistence. The American Journal of Tropical Medicine and Hygiene. PMID 34280146 DOI: 10.4269/ajtmh.21-0191  0.314
2021 Shardell M, Gravitt PE, Burke AE, Ravel J, Brotman RM. Association of Vaginal Microbiota with Signs and Symptoms of the Genitourinary Syndrome of Menopause across Reproductive Stages. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 33903897 DOI: 10.1093/gerona/glab120  0.556
2021 Miles TT, Riley-Powell AR, Lee GO, Gotlieb EE, Barth GC, Tran EQ, Ortiz K, Huaynate CA, Cabrera L, Gravitt PE, Oberhelman RA, Paz-Soldan VA. Knowledge, attitudes, and practices of cervical cancer prevention and pap smears in two low-income communities in Lima, Peru. Bmc Women's Health. 21: 168. PMID 33882904 DOI: 10.1186/s12905-021-01291-8  0.334
2021 Hammer A, Gravitt P. Clinical implications of transitioning from cytology to human papillomavirus-based cervical cancer screening. Acta Obstetricia Et Gynecologica Scandinavica. 100: 371-372. PMID 33739440 DOI: 10.1111/aogs.14107  0.365
2021 Gravitt PE, Silver MI, Hussey HM, Arrossi S, Huchko M, Jeronimo J, Kapambwe S, Kumar S, Meza G, Nervi L, Paz-Soldan VA, Woo YL. Achieving equity in cervical cancer screening in low- and middle-income countries (LMICs): Strengthening health systems using a systems thinking approach. Preventive Medicine. 144: 106322. PMID 33678230 DOI: 10.1016/j.ypmed.2020.106322  0.344
2021 Woo YL, Gravitt P, Khor SK, Ng CW, Saville M. Accelerating action on cervical screening in lower- and middle-income countries (LMICs) post COVID-19 era. Preventive Medicine. 144: 106294. PMID 33678225 DOI: 10.1016/j.ypmed.2020.106294  0.312
2021 Nowak RG, Liska TA, Bentzen SM, Kim E, Chipato T, Salata RA, Celentano DD, Morrison CS, Gravitt PE. Herpes Simplex Virus Type-2 shedding and genital ulcers during early HIV in Zimbabwean women. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 33587502 DOI: 10.1097/QAI.0000000000002641  0.603
2021 Khoo SP, Shafii MKA, Bhoo-Pathy N, Yap SH, Subramaniam S, Nasir NH, Lin Z, Belinson J, Goh PP, Qu X, Gravitt P, Woo YL. Prevalence and sociodemographic correlates of anogenital Human Papillomavirus (HPV) carriage in a cross-sectional, multi-ethnic, community-based Asian male population. Plos One. 16: e0245731. PMID 33471825 DOI: 10.1371/journal.pone.0245731  0.555
2020 Khoo SP, Lim WT, Rajasuriar R, Nasir NH, Gravitt PE, Woo YL. The acceptability and preference of vaginal self-sampling for human papillomavirus (HPV) testing among a multi-ethnic Asian female population. Cancer Prevention Research (Philadelphia, Pa.). PMID 32917643 DOI: 10.1158/1940-6207.CAPR-20-0280  0.482
2020 Imburgia TM, Shew ML, Gravitt PE, Katzenellenbogen RA. Considerations for Child Cancer Survivors and Immunocompromised Children to Prevent Secondary HPV-associated Cancers. Transplantation. PMID 32890137 DOI: 10.1097/TP.0000000000003444  0.529
2020 Paul P, Hammer A, Rositch AF, Burke AE, Viscidi RP, Silver MI, Campos N, Youk AO, Gravitt PE. Rates of new human papillomavirus detection and loss of detection in middle-aged women by recent and past sexual behavior. The Journal of Infectious Diseases. PMID 32870982 DOI: 10.1093/Infdis/Jiaa557  0.533
2020 Rositch AF, Patel EU, Petersen MR, Quinn TC, Gravitt PE, Tobian AAR. Importance of lifetime sexual history on the prevalence of genital human papillomavirus among unvaccinated adults in NHANES: implications for adult HPV vaccination. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32710745 DOI: 10.1093/Cid/Ciaa1050  0.49
2020 Castle PE, Pierz AJ, Adcock R, Aslam S, Basu PS, Belinson JL, Cuzick J, El-Zein M, Ferreccio C, Firnhaber C, Franco EL, Gravitt PE, Isidean SD, Lin J, Mahmud SM, et al. A pooled analysis to compare the clinical characteristics of human papillomavirus-positive and -negative cervical precancers. Cancer Prevention Research (Philadelphia, Pa.). PMID 32655005 DOI: 10.1158/1940-6207.Capr-20-0182  0.728
2020 Borgogna JC, Shardell MD, Santori EK, Nelson TM, Rath JM, Glover ED, Ravel J, Gravitt P, Yeoman CJ, Brotman RM. Authors' reply re: The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysis. Bjog : An International Journal of Obstetrics and Gynaecology. PMID 32154972 DOI: 10.1111/1471-0528.16148  0.792
2020 Hammer A, Demarco M, Campos N, Befano B, Gravitt PE, Cheung L, Lorey TS, Poitras N, Kinney W, Wentzensen N, Castle PE, Schiffman M. Study of the Risks of CIN3+ detection following multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California. International Journal of Cancer. PMID 32141607 DOI: 10.1002/Ijc.32950  0.728
2019 Borgogna JC, Shardell MD, Santori EK, Nelson TM, Rath JM, Glover ED, Ravel J, Gravitt PE, Yeoman CJ, Brotman RM. The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysis. Bjog : An International Journal of Obstetrics and Gynaecology. PMID 31749298 DOI: 10.1111/1471-0528.15981  0.806
2019 Castle PE, Adcock R, Cuzick J, Wentzensen N, Torrez-Martinez NE, Torres SM, Stoler MH, Ronnett BM, Joste NE, Darragh TM, Gravitt PE, Schiffman M, Hunt WC, Kinney WK, Wheeler CM, et al. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology. Archives of Pathology & Laboratory Medicine. PMID 31718233 DOI: 10.5858/Arpa.2019-0241-Oa  0.554
2019 Baezconde-Garbanati L, Agurto I, Gravitt PE, Luciani S, Murphy S, Ochoa C, Gallegos K, Barahona R, Rodríguez Y. Barriers and innovative interventions for early detection of cervical cancer. Salud Publica De Mexico. 61: 456-460. PMID 31430087 DOI: 10.21149/10425  0.399
2019 Holm JB, Humphrys MS, Robinson CK, Settles ML, Ott S, Fu L, Yang H, Gajer P, He X, McComb E, Gravitt PE, Ghanem KG, Brotman RM, Ravel J. Ultrahigh-Throughput Multiplexing and Sequencing of >500-Base-Pair Amplicon Regions on the Illumina HiSeq 2500 Platform. Msystems. 4. PMID 30801027 DOI: 10.1128/mSystems.00029-19  0.497
2019 Hammer A, de Koning MN, Blaakaer J, Steiniche T, Doorbar J, Griffin H, Mejlgaard E, Svanholm H, Quint WG, Gravitt PE. Whole tissue cervical mapping of HPV infection: molecular evidence for focal latent HPV infection in humans. Papillomavirus Research (Amsterdam, Netherlands). PMID 30772498 DOI: 10.1016/j.pvr.2019.02.004  0.632
2019 Mark K, Frost A, Hussey H, Lopez-Acevedo M, Burke AE, Edwardson J, Solaru O, Gravitt P. Rates of regression of cervical dysplasia between initial biopsy and excisional procedure in routine clinical practice. Archives of Gynecology and Obstetrics. PMID 30607589 DOI: 10.1007/S00404-018-5026-8  0.416
2019 Gravitt P. J-107 Interrogating the immunologic and microbial cervical microenvironment in HPV infection Jaids Journal of Acquired Immune Deficiency Syndromes. 81: 53. DOI: 10.1097/01.Qai.0000558000.85397.59  0.669
2018 Brotman RM, Shardell MD, Gajer P, Fadrosh D, Chang K, Silver MI, Viscidi RP, Burke AE, Ravel J, Gravitt PE. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause (New York, N.Y.). 25: 1321-1330. PMID 30358729 DOI: 10.1097/GME.0000000000001236  0.56
2018 Gravitt PE, Landy R, Schiffman M. How confident can we be in the current guidelines for exiting cervical screening? Preventive Medicine. PMID 29981791 DOI: 10.1016/J.Ypmed.2018.07.005  0.581
2018 Patel EU, Grabowski MK, Eisenberg AL, Packman ZR, Gravitt PE, Tobian AAR. Increases in Human Papillomavirus Vaccination Among Adolescent and Young Adult Males in the United States, 2011-2016. The Journal of Infectious Diseases. PMID 29584878 DOI: 10.1093/infdis/jiy165  0.411
2018 Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Chan PKS, Burk RD. Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). Virology. 516: 86-101. PMID 29331867 DOI: 10.1016/J.Virol.2018.01.002  0.684
2018 Hammer A, Hee L, Blaakær J, Gravitt P. Temporal Patterns of Cervical Cancer Screening Among Danish Women 55 Years and Older Diagnosed With Cervical Cancer. Journal of Lower Genital Tract Disease. 22: 1-7. PMID 29271849 DOI: 10.1097/Lgt.0000000000000351  0.441
2018 Yong C, Hong L, Lee K, Krishnasamy I, Nasir NB, Gravitt P, Lee Y, Woo Y. Healthcare Providers´ Views on Cervical Screening: A Qualitative Study of Barriers to Cervical Screening in Malaysia Journal of Global Oncology. 4: 214s-214s. DOI: 10.1200/Jgo.18.86300  0.436
2018 Hong L, Yong J, Lee K, Nasir NB, Gravitt P, Lee Y, Woo Y. Understanding Barriers to Cervical Screening Follow-Up and Treatment Compliance in Malaysia: A Qualitative Study of Provider Perspectives Journal of Global Oncology. 4: 214s-214s. DOI: 10.1200/Jgo.18.86200  0.4
2018 Borgogna J, Santori E, Nelson T, Ravel J, Shardell M, Gravitt P, Brotman R, Yeoman C. HPV is associated with an altered metabolomic profile in the vaginal tract American Journal of Obstetrics and Gynecology. 219: 636. DOI: 10.1016/J.Ajog.2018.10.071  0.788
2017 Khoo SP, Bhoo-Pathy N, Yap SH, Anwar Shafii MK, Hairizan Nasir N, Belinson J, Subramaniam S, Goh PP, Zeng M, Tan HD, Gravitt P, Woo YL. Prevalence and sociodemographic correlates of cervicovaginal human papillomavirus (HPV) carriage in a cross-sectional, multiethnic, community-based female Asian population. Sexually Transmitted Infections. PMID 29180538 DOI: 10.1136/Sextrans-2017-053320  0.663
2017 Silver MI, Rositch AF, Phelan-Emrick DF, Gravitt PE. Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years. Cancer Causes & Control : Ccc. PMID 29124542 DOI: 10.1007/S10552-017-0976-X  0.588
2017 Eldridge RC, Pawlita M, Wilson L, Castle PE, Waterboer T, Gravitt PE, Schiffman M, Wentzensen N. Smoking and subsequent human papillomavirus infection: a mediation analysis. Annals of Epidemiology. PMID 29107447 DOI: 10.1016/J.Annepidem.2017.10.004  0.702
2017 Gravitt PE. Unraveling the Epidemiology of Oral Human Papillomavirus Infection. Annals of Internal Medicine. PMID 29049824 DOI: 10.7326/M17-2628  0.344
2017 Gravitt PE, Winer RL. Natural History of HPV Infection across the Lifespan: Role of Viral Latency. Viruses. 9. PMID 28934151 DOI: 10.3390/V9100267  0.629
2017 Ryser MD, Rositch A, Gravitt PE. Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution. The Journal of Infectious Diseases. 216: 604-611. PMID 28931221 DOI: 10.1093/Infdis/Jix333  0.604
2017 Ryser MD, Gravitt PE, Myers ER. Mechanistic mathematical models: An underused platform for HPV research. Papillomavirus Research (Amsterdam, Netherlands). 3: 46-49. PMID 28720456 DOI: 10.1016/J.Pvr.2017.01.004  0.482
2017 Patel EU, Rositch AF, Gravitt PE, Tobian AAR. Concordance of Penile and Oral Human Papillomavirus Infections Among Men in the United States. The Journal of Infectious Diseases. 215: 1207-1211. PMID 28329127 DOI: 10.1093/Infdis/Jix116  0.604
2017 Gravitt PE. Human papillomavirus: the equal opportunity infection. The Journal of Infectious Diseases. PMID 28170038 DOI: 10.1093/infdis/jix058  0.326
2017 Borgogna J, Santori EK, Nelson TM, Ravel J, Shardell M, Gravitt P, Brotman RM, Yeoman CJ. P1.27 Hpv is associated with an altered metabolomic profile in the vaginal tract Sexually Transmitted Infections. 93. DOI: 10.1136/Sextrans-2017-053264.135  0.804
2016 Grabowski MK, Gravitt PE, Gray RH, Serwadda D, Redd AD, Kigozi G, Kong X, Nalugoda F, Wawer MJ, Quinn TC, Tobian AA. Trends and determinants of human papillomavirus concordance among HIV-positive and HIV-negative heterosexual couples in Rakai, Uganda. The Journal of Infectious Diseases. PMID 28011913 DOI: 10.1093/Infdis/Jiw631  0.333
2016 Hammer A, Kahlert J, Rositch A, Pedersen L, Gravitt P, Blaakaer J, Soegaard M. The temporal and age-dependent patterns of hysterectomy corrected cervical cancer incidence rates in Denmark: a population based cohort study. Acta Obstetricia Et Gynecologica Scandinavica. PMID 27861705 DOI: 10.1111/Aogs.13057  0.456
2016 Rudolph SE, Lorincz A, Wheeler CM, Gravitt P, Lazcano-Ponce E, Torres-Ibarra L, León-Maldonado L, Ramírez P, Rivera B, Hernández R, Franco EL, Cuzick J, Méndez-Hernández P, Salmerón J. Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico. Bmc Infectious Diseases. 16: 461. PMID 27585544 DOI: 10.1186/S12879-016-1782-X  0.674
2016 Torres-Ibarra L, Lazcano-Ponce E, Franco EL, Cuzick J, Hernández-Ávila M, Lorincz A, Rivera B, Ramírez P, Mendiola-Pastrana I, Rudolph SE, León-Maldonado L, Hernández R, Barrios E, Gravitt P, Moscicki AB, et al. Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study. Salud PúBlica De MéXico. 58: 197-210. PMID 27557378 DOI: 10.21149/Spm.V58I2.7789  0.56
2016 Ma'som M, Bhoo-Pathy N, Nasir NH, Bellinson J, Subramaniam S, Ma Y, Yap SH, Goh PP, Gravitt P, Woo YL. Attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women. Bmj Open. 6: e011022. PMID 27491667 DOI: 10.1136/Bmjopen-2015-011022  0.531
2016 Nowak RG, Gravitt PE, He X, Ketende S, Dauda W, Omuh H, Blattner WA, Charurat ME. Prevalence of Anal High-Risk Human Papillomavirus Infections Among HIV-Positive and HIV-Negative Men Who Have Sex With Men in Nigeria. Sexually Transmitted Diseases. 43: 243-248. PMID 26967301 DOI: 10.1097/Olq.0000000000000431  0.704
2016 Rettig EM, Fakhry C, Rositch AF, Burke AE, Chang K, Silver MI, Viscidi R, Gravitt P. Race Is Associated With Sexual Behaviors and Modifies the Effect of Age on Human Papillomavirus Serostatus Among Perimenopausal Women. Sexually Transmitted Diseases. 43: 231-237. PMID 26967299 DOI: 10.1097/Olq.0000000000000426  0.599
2016 Brotherton JM, Jit M, Gravitt PE, Brisson M, Kreimer AR, Pai SI, Fakhry C, Monsonego J, Franceschi S. Eurogin Roadmap 2015: How has HPV knowledge changed our practice: vaccines. International Journal of Cancer. Journal International Du Cancer. PMID 26916230 DOI: 10.1002/Ijc.30063  0.525
2016 Gravitt PE. HPV Seroprevalence in the United States: Behavior, Biology, and Prevention. The Journal of Infectious Diseases. 213: 171-2. PMID 26320258 DOI: 10.1093/infdis/jiv405  0.487
2016 Nowak R, Gravitt P, He X, Ketende S, Anom W, Omuh H, Blattner W, Charurat M. P-B18 Prevalence of anal high-risk human papillomavirus infections among HIV-positive and HIV-negative men who have sex with men (MSM) in Nigeria Jaids Journal of Acquired Immune Deficiency Syndromes. 71: 80. DOI: 10.1097/01.Qai.0000479736.51946.De  0.657
2016 Gravitt P, Patterson N, Stanislawski E, Colquitt E, Norville S, Cuzick J, Wheeler CM. Prevalence of Sexually Transmitted Infections and Coinfection in a Population-Based Sample of Women Attending Cervical Cancer Screening in New Mexico, United States of America Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.1003  0.429
2016 Peedicayil A, Abraham P, Prasad J, Jeyaseelan L, Abraham S, Kurian S, Gravitt P, Shah KV. Community Prevalence of Human Papillomavirus by Self-Collected Samples in South India Indian Journal of Gynecologic Oncology. 14. DOI: 10.1007/S40944-016-0045-5  0.631
2016 Torres-Ibarra L, Lazcano-Ponce E, Franco EL, Cuzick J, Hernández-Ávila M, Lorincz A, Rivera B, Ramírez P, Mendiola-Pastrana I, Rudolph SE, León-Maldonado L, Hernández R, Barrios E, Gravitt P, Moscicki AB, et al. Triage strategies in cervical cancer detection in Mexico: Methods of the FRIDA study Salud Publica De Mexico. 58: 197-210.  0.595
2015 Hammer A, Rositch A, Qeadan F, Gravitt PE, Blaakaer J. Age-specific prevalence of HPV16/18 genotypes in cervical cancer: a systematic review and meta-analysis. International Journal of Cancer. Journal International Du Cancer. PMID 26661889 DOI: 10.1002/Ijc.29959  0.53
2015 Grabowski MK, Kong X, Gray RH, Serwadda D, Kigozi G, Gravitt PE, Nalugoda F, Reynolds SJ, Wawer MJ, Redd AD, Watya S, Quinn TC, Tobian AA. Partner human papillomavirus viral load and incident human papillomavirus detection in heterosexual couples. The Journal of Infectious Diseases. PMID 26597261 DOI: 10.1093/Infdis/Jiv541  0.549
2015 Gravitt PE, Marks M, Kosek M, Huang C, Cabrera L, Olortegui MP, Mejia Medrano A, Trigoso DR, Qureshi S, Bardales GS, Manrique-Hinojosa J, Cardenas AZ, Larraondo MA, Cok J, Qeadan F, et al. Soil transmitted helminth infections are associated with an increase in human papillomavirus prevalence and a Th2 cytokine signature in cervical fluids. The Journal of Infectious Diseases. PMID 26486638 DOI: 10.1093/Infdis/Jiv498  0.475
2015 Hammer A, Mejlgaard E, Gravitt P, Høgdall E, Christiansen P, Steiniche T, Blaakaer J. HPV genotype distribution in older Danish women undergoing surgery due to cervical cancer. Acta Obstetricia Et Gynecologica Scandinavica. 94: 1262-8. PMID 26300424 DOI: 10.1111/Aogs.12731  0.648
2015 Rosen BJ, Walter L, Gilman RH, Cabrerra L, Gravitt PE, Marks MA. Prevalence and correlates of oral human papillomavirus infection among healthy males and females in Lima, Peru. Sexually Transmitted Infections. PMID 26275415 DOI: 10.1136/Sextrans-2014-051942  0.554
2015 Wang JW, Jagu S, Wu WH, Viscidi RP, Macgregor-Das A, Fogel JM, Kwak K, Daayana S, Kitchener H, Stern PL, Gravitt PE, Trimble CL, Roden RB. Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies. Clinical and Vaccine Immunology : Cvi. 22: 806-16. PMID 25972404 DOI: 10.1128/Cvi.00799-14  0.53
2015 Marks MA, Gupta S, Liaw KL, Tadesse A, Kim E, Phongnarisorn C, Wootipoom V, Yuenyao P, Vipupinyo C, Rugpao S, Sriplienchan S, Gravitt PE, Celentano DD. Prevalence and correlates of HPV among women attending family-planning clinics in Thailand. Bmc Infectious Diseases. 15: 159. PMID 25887797 DOI: 10.1186/S12879-015-0886-Z  0.572
2015 Silver MI, Rositch AF, Burke AE, Chang K, Viscidi R, Gravitt PE. Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening. Obstetrics and Gynecology. 125: 317-29. PMID 25568994 DOI: 10.1097/Aog.0000000000000638  0.373
2015 Low HC, Silver MI, Brown BJ, Leng CY, Blas MM, Gravitt PE, Woo YL. Comparison of Hybribio GenoArray and Roche human papillomavirus (HPV) linear array for HPV genotyping in anal swab samples. Journal of Clinical Microbiology. 53: 550-6. PMID 25502520 DOI: 10.1128/Jcm.02274-14  0.581
2015 Wang JW, Jagu S, Wu WH, Viscidi RP, Macgregor-Das A, Fogel JM, Kwak K, Daayana S, Kitchener H, Stern PL, Gravitt PE, Trimble CL, Roden RBS. Seroepidemiology of human papillomavirus 16 (HPV16) L2 and generation of L2-specific human chimeric monoclonal antibodies Clinical and Vaccine Immunology. 22: 806-816. DOI: 10.1128/CVI.00799-14  0.416
2014 Safaeian M, Johnson LG, Yu K, Wang SS, Gravitt PE, Hansen JA, Carrington M, Schwartz SM, Gao X, Hildesheim A, Madeleine MM. Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma. Frontiers in Oncology. 4: 119. PMID 24995157 DOI: 10.3389/Fonc.2014.00119  0.617
2014 Brotman RM, Shardell MD, Gajer P, Tracy JK, Zenilman JM, Ravel J, Gravitt PE. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. The Journal of Infectious Diseases. 210: 1723-33. PMID 24943724 DOI: 10.1093/Infdis/Jiu330  0.778
2014 Sahasrabuddhe VV, Gravitt PE, Dunn ST, Robbins D, Brown D, Allen RA, Eby YJ, Smith KM, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N. Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 60: 414-7. PMID 24881489 DOI: 10.1016/J.Jcv.2014.04.016  0.686
2014 Rositch AF, Nowak RG, Gravitt PE. Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009. Cancer. 120: 2032-8. PMID 24821088 DOI: 10.1002/Cncr.28548  0.669
2014 Wilson L, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N. Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection. The Journal of Infectious Diseases. 210: 448-55. PMID 24569064 DOI: 10.1093/Infdis/Jiu104  0.787
2014 Grabowski MK, Gray RH, Serwadda D, Kigozi G, Gravitt PE, Nalugoda F, Reynolds SJ, Wawer MJ, Watya S, Quinn TC, Tobian AA. High-risk human papillomavirus viral load and persistence among heterosexual HIV-negative and HIV-positive men. Sexually Transmitted Infections. 90: 337-43. PMID 24482488 DOI: 10.1136/Sextrans-2013-051230  0.557
2014 Gravitt PE, Rositch AF. HPV self-testing and cervical cancer screening coverage. The Lancet. Oncology. 15: 128-9. PMID 24433681 DOI: 10.1016/S1470-2045(13)70605-3  0.519
2014 Sahasrabuddhe VV, Gravitt PE, Dunn ST, Brown D, Allen RA, Eby YJ, Smith K, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N. Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. Journal of Clinical Microbiology. 52: 187-92. PMID 24197879 DOI: 10.1128/Jcm.01623-13  0.726
2014 Brotman RM, Ravel J, Bavoil PM, Gravitt PE, Ghanem KG. Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections. Vaccine. 32: 1543-52. PMID 24135572 DOI: 10.1016/J.Vaccine.2013.10.010  0.506
2014 Liu SH, Cummings DA, Zenilman JM, Gravitt PE, Brotman RM. Characterizing the temporal dynamics of human papillomavirus DNA detectability using short-interval sampling. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 200-8. PMID 24130223 DOI: 10.1158/1055-9965.Epi-13-0666  0.856
2014 Brotman RM, Shardell MD, Gajer P, Fadrosh D, Chang K, Silver MI, Viscidi RP, Burke AE, Ravel J, Gravitt PE. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause (New York, N.Y.). 21: 450-8. PMID 24080849 DOI: 10.1097/Gme.0B013E3182A4690B  0.56
2014 Walter L, Vidaurre T, Gilman RH, Poquioma E, Olaechea C, Gravitt PE, Marks MA. Trends in head and neck cancers in Peru between 1987 and 2008: Experience from a large public cancer hospital in Lima. Head & Neck. 36: 729-34. PMID 23616366 DOI: 10.1002/Hed.23369  0.501
2014 Paul P, Tanner AE, Gravitt PE, Vijayaraghavan K, Shah KV, Zimet GD, Study Group C. Acceptability of HPV vaccine implementation among parents in India. Health Care For Women International. 35: 1148-61. PMID 23611111 DOI: 10.1080/07399332.2012.740115  0.431
2014 Peedicayil A, Abraham P, Prasad J, Abraham S, Jeyaseelan L, Gnanamony M, Gravitt P, Kurian S. The community prevalence of human papillomavirus (HPV) in India and the feasibility of self-collected vaginal swabs Gynecologic Oncology. 133: 15. DOI: 10.1016/j.ygyno.2014.03.058  0.526
2013 Vogt SL, Gravitt PE, Martinson NA, Hoffmann J, D'Souza G. Concordant Oral-Genital HPV Infection in South Africa Couples: Evidence for Transmission. Frontiers in Oncology. 3: 303. PMID 24377087 DOI: 10.3389/fonc.2013.00303  0.757
2013 Fakhry C, Marks MA, Gilman RH, Cabrerra L, Yori P, Kosek M, Gravitt PE. Comparison of the immune microenvironment of the oral cavity and cervix in healthy women. Cytokine. 64: 597-604. PMID 24021705 DOI: 10.1016/J.Cyto.2013.08.009  0.407
2013 Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. Plos One. 8: e72565. PMID 23977318 DOI: 10.1371/Journal.Pone.0072565  0.692
2013 Liu SH, Brotman RM, Zenilman JM, Gravitt PE, Cummings DA. Menstrual cycle and detectable human papillomavirus in reproductive-age women: a time series study. The Journal of Infectious Diseases. 208: 1404-15. PMID 23885113 DOI: 10.1093/Infdis/Jit337  0.854
2013 Rositch AF, Gravitt PE, Smith JS. Growing evidence that HPV infection is associated with an increase in HIV acquisition: exploring the issue of HPV vaccination. Sexually Transmitted Infections. 89: 357. PMID 23858496 DOI: 10.1136/Sextrans-2012-050870  0.583
2013 Liu SH, Rositch AF, Viscidi RP, Silver MI, Burke AE, Gravitt PE. Obesity and human papillomavirus infection in perimenopausal women. The Journal of Infectious Diseases. 208: 1071-80. PMID 23840046 DOI: 10.1093/Infdis/Jit297  0.762
2013 Gage JC, Schiffman M, Solomon D, Wheeler CM, Gravitt PE, Castle PE, Wentzensen N. Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1095-101. PMID 23603204 DOI: 10.1158/1055-9965.Epi-12-1455  0.734
2013 Wilson LE, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N. Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. International Journal of Cancer. Journal International Du Cancer. 133: 2172-81. PMID 23588935 DOI: 10.1002/Ijc.28215  0.806
2013 Davis MA, Gray RH, Grabowski MK, Serwadda D, Kigozi G, Gravitt PE, Nalugoda F, Watya S, Wawer MJ, Quinn TC, Tobian AA. Male circumcision decreases high-risk human papillomavirus viral load in female partners: a randomized trial in Rakai, Uganda. International Journal of Cancer. Journal International Du Cancer. 133: 1247-52. PMID 23400966 DOI: 10.1002/Ijc.28100  0.588
2013 Schluterman NH, Sow SO, Traore CB, Bakarou K, Dembelé R, Sacko F, Gravitt PE, Tracy JK. Differences in patterns of high-risk human papillomavirus infection between urban and rural low-resource settings: cross-sectional findings from Mali. Bmc Women's Health. 13: 4. PMID 23388094 DOI: 10.1186/1472-6874-13-4  0.571
2013 Rositch AF, Gravitt PE, Tobian AA, Newell K, Quinn TC, Serwadda D, Ssebbowa P, Kiggundu V, Gray RH, Reynolds SJ. Frequent detection of HPV before and after initiation of antiretroviral therapy among HIV/HSV-2 co-infected women in Uganda. Plos One. 8: e55383. PMID 23383171 DOI: 10.1371/Journal.Pone.0055383  0.618
2013 Guan Y, Gravitt PE, Howard R, Eby YJ, Wang S, Li B, Feng C, Qiao YL, Castle PE. Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens. Journal of Virological Methods. 189: 167-71. PMID 23370404 DOI: 10.1016/j.jviromet.2012.11.010  0.535
2013 Castle PE, Gage JC, Partridge EE, Rausa A, Gravitt PE, Scarinci IC. Human papillomavirus genotypes detected in clinician-collected and self-collected specimens from women living in the Mississippi Delta. Bmc Infectious Diseases. 13: 5. PMID 23289357 DOI: 10.1186/1471-2334-13-5  0.578
2013 Gravitt PE, Rositch AF, Silver MI, Marks MA, Chang K, Burke AE, Viscidi RP. A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States. The Journal of Infectious Diseases. 207: 272-80. PMID 23242540 DOI: 10.1093/Infdis/Jis660  0.54
2013 Wilson LE, Gravitt P, Tobian AA, Kigozi G, Serwadda D, Nalugoda F, Watya S, Wawer MJ, Gray RH. Male circumcision reduces penile high-risk human papillomavirus viral load in a randomised clinical trial in Rakai, Uganda. Sexually Transmitted Infections. 89: 262-6. PMID 23112341 DOI: 10.1136/Sextrans-2012-050633  0.733
2013 Yemelyanova A, Gravitt PE, Ronnett BM, Rositch AF, Ogurtsova A, Seidman J, Roden RB. Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 268-74. PMID 22996373 DOI: 10.1038/modpathol.2012.156  0.382
2013 El-Serag HB, Hollier JM, Gravitt P, Alsarraj A, Younes M. Human papillomavirus and the risk of Barrett's esophagus Diseases of the Esophagus. 26: 517-521. PMID 22891654 DOI: 10.1111/j.1442-2050.2012.01392.x  0.574
2013 Rositch AF, Silver MI, Burke A, Viscidi R, Chang K, Duke CM, Shen W, Gravitt PE. The correlation between human papillomavirus positivity and abnormal cervical cytology result differs by age among perimenopausal women. Journal of Lower Genital Tract Disease. 17: 38-47. PMID 22885643 DOI: 10.1097/Lgt.0B013E3182503402  0.568
2013 Tobian AA, Grabowski MK, Kigozi G, Gravitt PE, Eaton KP, Serwadda D, Nalugoda F, Wawer MJ, Quinn TC, Gray RH. High-risk human papillomavirus prevalence is associated with HIV infection among heterosexual men in Rakai, Uganda. Sexually Transmitted Infections. 89: 122-7. PMID 22628661 DOI: 10.1136/Sextrans-2012-050524  0.606
2013 Grabowski MK, Gray RH, Serwadda D, Kigozi G, Gravitt PE, Nalugoda F, Renyolds SJ, Wawer M, Quinn TC, Tobian AAR. P3.222 High Risk Human Papillomavirus Viral Load and Persistence Among HIV-Negative and HIV-Positive Men Sexually Transmitted Infections. 89: A217.3-A218. DOI: 10.1136/Sextrans-2013-051184.0679  0.517
2013 Brotman RM, Shardell MD, Gajer P, Tracy JK, Zenilman JM, Ravel J, Gravitt PE. O05.5 A Longitudinal Study of the Vaginal Microbiota and HPV Detection Sexually Transmitted Infections. 89: A36.1-A36. DOI: 10.1136/Sextrans-2013-051184.0111  0.824
2013 Davis M, Grabowski M, Gravitt P, Gray R, Kigozi G, Nalugoda F, Serwadda D, Tobian A, Watya S, Wawer M. Male circumcision reduces high-risk human papillomavirus (HPV) viral shedding in female partners in Rakai, Uganda Gynecologic Oncology. 130: e26-e27. DOI: 10.1016/J.Ygyno.2013.04.124  0.593
2012 Cuzick J, Bergeron C, von Knebel Doeberitz M, Gravitt P, Jeronimo J, Lorincz AT, J L M Meijer C, Sankaranarayanan R, J F Snijders P, Szarewski A. New technologies and procedures for cervical cancer screening. Vaccine. 30: F107-16. PMID 23199953 DOI: 10.1016/J.Vaccine.2012.05.088  0.679
2012 Rositch AF, Burke AE, Viscidi RP, Silver MI, Chang K, Gravitt PE. Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women. Cancer Research. 72: 6183-90. PMID 23019223 DOI: 10.1158/0008-5472.Can-12-2635  0.55
2012 Castle PE, Gravitt PE, Wentzensen N, Schiffman M. A descriptive analysis of prevalent vs incident cervical intraepithelial neoplasia grade 3 following minor cytologic abnormalities. American Journal of Clinical Pathology. 138: 241-6. PMID 22904136 DOI: 10.1309/Ajcpntk6G2Pxwhoo  0.681
2012 Tatsas AD, Phelan DF, Gravitt PE, Boitnott JK, Clark DP. Practice patterns in cervical cancer screening and human papillomavirus testing. American Journal of Clinical Pathology. 138: 223-9. PMID 22904133 DOI: 10.1309/AJCPPVX91HQMNYZZ  0.313
2012 Houlihan CF, Larke NL, Watson-Jones D, Smith-McCune KK, Shiboski S, Gravitt PE, Smith JS, Kuhn L, Wang C, Hayes R. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. Aids (London, England). 26: 2211-22. PMID 22874522 DOI: 10.1097/Qad.0B013E328358D908  0.488
2012 Guan Y, Castle PE, Wang S, Li B, Feng C, Ci P, Li X, Gravitt P, Qiao YL. A cross-sectional study on the acceptability of self-collection for HPV testing among women in rural China. Sexually Transmitted Infections. 88: 490-4. PMID 22645391 DOI: 10.1136/Sextrans-2012-050477  0.494
2012 Brown B, Blas MM, Cabral A, Byraiah G, Guerra-Giraldez C, Sarabia-Vega V, Carcamo C, Gravitt PE, Halsey NA. Human papillomavirus prevalence, cervical abnormalities and risk factors among female sex workers in Lima, Peru. International Journal of Std & Aids. 23: 242-7. PMID 22581946 DOI: 10.1258/Ijsa.2011.011193  0.645
2012 Tobian AA, Kigozi G, Gravitt PE, Xiao C, Serwadda D, Eaton KP, Kong X, Wawer MJ, Nalugoda F, Quinn TC, Gray RH. Human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in sub-Saharan Africa. Aids (London, England). 26: 1555-65. PMID 22441255 DOI: 10.1097/Qad.0B013E328353B83C  0.521
2012 Wentzensen N, Gravitt PE, Long R, Schiffman M, Dunn ST, Carreon JD, Allen RA, Gunja M, Zuna RE, Sherman ME, Gold MA, Walker JL, Wang SS. Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens. Journal of Clinical Microbiology. 50: 1564-70. PMID 22337992 DOI: 10.1128/Jcm.06240-11  0.698
2012 Brown B, Blas M, Cabral A, Carcamo C, Gravitt P, Halsey N. Randomized trial of HPV4 vaccine assessing the response to HPV4 vaccine in two schedules among Peruvian female sex workers. Vaccine. 30: 2309-14. PMID 22306855 DOI: 10.1016/J.Vaccine.2012.01.058  0.625
2012 Marks MA, Castle PE, Schiffman M, Gravitt PE. Evaluation of any or type-specific persistence of high-risk human papillomavirus for detecting cervical precancer. Journal of Clinical Microbiology. 50: 300-6. PMID 22162556 DOI: 10.1128/Jcm.05979-11  0.721
2012 Setse R, Siberry GK, Moss WJ, Gravitt P, Wheeling T, Bohannon B, Dominguez K. Cervical pap screening cytological abnormalities among HIV-infected adolescents in the LEGACY cohort. Journal of Pediatric and Adolescent Gynecology. 25: 27-34. PMID 22088311 DOI: 10.1016/J.Jpag.2011.09.002  0.312
2012 El-Serag H, Hollier JM, Alsarraj A, Gravitt P, Younes M. Su1167 Human Papilloma Virus (HPV) and the Risk of Barrett's Esophagus Gastroenterology. 142: S-442. DOI: 10.1016/S0016-5085(12)61662-X  0.523
2012 Soong T, Silver M, Chang K, Shen W, Howard R, Burke A, Gravitt P. Progestin-Only Contraceptive Use Is Independent Predictor of HPV Prevalence in Women Aged Over 35 Years Annals of Epidemiology. 22: 672. DOI: 10.1016/j.annepidem.2012.06.055  0.527
2011 Gravitt PE. The known unknowns of HPV natural history. The Journal of Clinical Investigation. 121: 4593-9. PMID 22133884 DOI: 10.1172/JCI57149  0.54
2011 Brown B, Blas MM, Cabral A, Carcamo C, Gravitt PE, Halsey N. Oral sex practices, oral human papillomavirus and correlations between oral and cervical human papillomavirus prevalence among female sex workers in Lima, Peru International Journal of Std and Aids. 22: 655-658. PMID 22096051 DOI: 10.1258/Ijsa.2011.010541  0.6
2011 Marks MA, Viscidi RP, Chang K, Silver M, Burke A, Howard R, Gravitt PE. Differences in the concentration and correlation of cervical immune markers among HPV positive and negative perimenopausal women. Cytokine. 56: 798-803. PMID 22015106 DOI: 10.1016/J.Cyto.2011.09.012  0.62
2011 Gage JC, Partridge EE, Rausa A, Gravitt PE, Wacholder S, Schiffman M, Scarinci I, Castle PE. Comparative performance of human papillomavirus DNA testing using novel sample collection methods. Journal of Clinical Microbiology. 49: 4185-9. PMID 21998422 DOI: 10.1128/Jcm.01254-11  0.618
2011 Marks M, Gravitt PE, Gupta SB, Liaw KL, Tadesse A, Kim E, Phongnarisorn C, Wootipoom V, Yuenyao P, Vipupinyo C, Sriplienchan S, Celentano DD. Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from Thailand. The Journal of Infectious Diseases. 204: 1505-13. PMID 21964399 DOI: 10.1093/Infdis/Jir560  0.59
2011 Vaccarella S, Plummer M, Franceschi S, Gravitt P, Papenfuss M, Smith D, Villa L, Ponce EL, Giuliano AR. Clustering of human papillomavirus (HPV) types in the male genital tract: the HPV in men (HIM) study. The Journal of Infectious Diseases. 204: 1500-4. PMID 21908729 DOI: 10.1093/Infdis/Jir595  0.665
2011 Phelan DF, Boitnott JK, Clark DP, Dubay LC, Gravitt PE. Trends of human papillomavirus testing in cervical cancer screening at a large academic cytology laboratory. Obstetrics and Gynecology. 118: 289-95. PMID 21775844 DOI: 10.1097/AOG.0b013e3182253c33  0.485
2011 Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. Plos One. 6: e20183. PMID 21673791 DOI: 10.1371/Journal.Pone.0020183  0.713
2011 Castle PE, Gutierrez EC, Leitch SV, Maus CE, McMillian RA, Nussbaumer WA, Vaughan LM, Wheeler CM, Gravitt PE, Schiffman M. Evaluation of a new DNA test for detection of carcinogenic human papillomavirus. Journal of Clinical Microbiology. 49: 3029-32. PMID 21632892 DOI: 10.1128/Jcm.00422-11  0.713
2011 Silver MI, Paul P, Sowjanya P, Ramakrishna G, Vedantham H, Kalpana B, Shah KV, Gravitt PE. Shedding of Epstein-Barr virus and cytomegalovirus from the genital tract of women in a periurban community in Andhra Pradesh, India. Journal of Clinical Microbiology. 49: 2435-9. PMID 21525227 DOI: 10.1128/JCM.02206-10  0.464
2011 Castle PE, Rausa A, Walls T, Gravitt PE, Partridge EE, Olivo V, Niwa S, Morrissey KG, Tucker L, Katki H, Scarinci I. Comparative community outreach to increase cervical cancer screening in the Mississippi Delta. Preventive Medicine. 52: 452-5. PMID 21497619 DOI: 10.1016/j.ypmed.2011.03.018  0.322
2011 Tobian AA, Kong X, Wawer MJ, Kigozi G, Gravitt PE, Serwadda D, Eaton KP, Nalugoda F, Quinn TC, Gray RH. Circumcision of HIV-infected men and transmission of human papillomavirus to female partners: analyses of data from a randomised trial in Rakai, Uganda. The Lancet. Infectious Diseases. 11: 604-12. PMID 21489882 DOI: 10.1016/S1473-3099(11)70038-X  0.461
2011 Tobian AA, Kong X, Gravitt PE, Eaton KP, Kigozi G, Serwadda D, Oliver AE, Nalugoda F, Makumbi F, Chen MZ, Wawer MJ, Quinn TC, Gray RH. Male circumcision and anatomic sites of penile high-risk human papillomavirus in Rakai, Uganda. International Journal of Cancer. Journal International Du Cancer. 129: 2970-5. PMID 21462185 DOI: 10.1002/Ijc.25957  0.615
2011 Nowak RG, Gravitt PE, Morrison CS, Gange SJ, Kwok C, Oliver AE, Howard R, Van Der Pol B, Salata RA, Padian NS, Chipato T, Munjoma M, Celentano DD. Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe Journal of Infectious Diseases. 203: 1182-1191. PMID 21451006 DOI: 10.1093/Infdis/Jiq172  0.71
2011 Yu KJ, Hsu WL, Pfeiffer RM, Chiang CJ, Wang CP, Lou PJ, Cheng YJ, Gravitt P, Diehl SR, Goldstein AM, Chen CJ, Hildesheim A. Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1906-14. PMID 21447725 DOI: 10.1158/1078-0432.Ccr-10-1681  0.588
2011 Marks M, Gravitt PE, Utaipat U, Gupta SB, Liaw K, Kim E, Tadesse A, Phongnarisorn C, Wootipoom V, Yuenyao P, Vipupinyo C, Rugpao S, Sriplienchan S, Celentano DD. Kinetics of DNA load predict HPV 16 viral clearance. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 51: 44-9. PMID 21388867 DOI: 10.1016/J.Jcv.2011.01.011  0.527
2011 Gravitt PE, Belinson JL, Salmeron J, Shah KV. Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy. International Journal of Cancer. Journal International Du Cancer. 129: 517-27. PMID 21384341 DOI: 10.1002/ijc.25974  0.535
2011 Tracy L, Gaff HD, Burgess C, Sow S, Gravitt PE, Tracy JK. Estimating the impact of human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 641-5. PMID 21252142 DOI: 10.1093/Cid/Ciq190  0.463
2011 Wawer MJ, Tobian AA, Kigozi G, Kong X, Gravitt PE, Serwadda D, Nalugoda F, Makumbi F, Ssempiija V, Sewankambo N, Watya S, Eaton KP, Oliver AE, Chen MZ, Reynolds SJ, et al. Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. Lancet. 377: 209-18. PMID 21216000 DOI: 10.1016/S0140-6736(10)61967-8  0.516
2011 Marks M, Gravitt PE, Gupta SB, Liaw KL, Kim E, Tadesse A, Phongnarisorn C, Wootipoom V, Yuenyao P, Vipupinyo C, Rugpao S, Sriplienchan S, Celentano DD. The association of hormonal contraceptive use and HPV prevalence. International Journal of Cancer. Journal International Du Cancer. 128: 2962-70. PMID 20734390 DOI: 10.1002/Ijc.25628  0.626
2011 Soong TR, Gravitt PE, Gupta SB, Tadesse A, Kim E, Phongnarisorn C, Wootipoom V, Yuenyao P, Celentano DD. O1-S02.02 Are there mutual associations between the incidence of HPV infection and other sexually transmitted infections after controlling for sexual behaviour? Sexually Transmitted Infections. 87: A23-A24. DOI: 10.1136/Sextrans-2011-050109.8  0.612
2011 Soong TR, Gravitt PE, Gupta SB, Liaw K, Tadesse A, Phongnarisorn C, Wootipoom V, Yuenyao P, Celentano DD. P1-S5.32 The differential associations of HPV prevalence with other sexually transmitted infections in hormonal and non-hormonal contraceptive users Sexually Transmitted Infections. 87: A188-A189. DOI: 10.1136/Sextrans-2011-050108.210  0.565
2010 Smith JS, Van Damme K, Randrianjafisamindrakotroka N, Ting J, Rabozakandraina T, Randrianasolo BS, Raharinivo M, Zanasaotra S, Hobbs M, Rinas A, Cohen M, Gravitt P, Behets F. Human papillomavirus and cervical neoplasia among female sex workers in Madagascar. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 20: 1593-6. PMID 21370602 DOI: 10.1111/Igc.0B013E3181F8C22E  0.682
2010 Piyathilake CJ, Badiga S, Paul P, Vijayaraghavan K, Vedantham H, Sudula M, Sowjanya P, Ramakrishna G, Shah KV, Partridge EE, Gravitt PE. Indian women with higher serum concentrations of folate and vitamin B12 are significantly less likely to be infected with carcinogenic or high-risk (HR) types of human papillomaviruses (HPVs). International Journal of Women's Health. 2: 7-12. PMID 21072292  0.543
2010 Gravitt PE, Paul P, Katki HA, Vendantham H, Ramakrishna G, Sudula M, Kalpana B, Ronnett BM, Vijayaraghavan K, Shah KV. Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India. Plos One. 5: e13711. PMID 21060889 DOI: 10.1371/journal.pone.0013711  0.535
2010 Wentzensen N, Wilson LE, Wheeler CM, Carreon JD, Gravitt PE, Schiffman M, Castle PE. Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study. Cancer Research. 70: 8578-86. PMID 20959485 DOI: 10.1158/0008-5472.Can-10-1188  0.757
2010 Schweizer J, Lu PS, Mahoney CW, Berard-Bergery M, Ho M, Ramasamy V, Silver JE, Bisht A, Labiad Y, Peck RB, Lim J, Jeronimo J, Howard R, Gravitt PE, Castle PE. Feasibility study of a human papillomavirus E6 oncoprotein test for diagnosis of cervical precancer and cancer. Journal of Clinical Microbiology. 48: 4646-8. PMID 20926711 DOI: 10.1128/JCM.01315-10  0.605
2010 Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1675-81. PMID 20615885 DOI: 10.1158/1055-9965.Epi-10-0251  0.707
2010 Vedantham H, Silver MI, Kalpana B, Rekha C, Karuna BP, Vidyadhari K, Mrudula S, Ronnett BM, Vijayaraghavan K, Ramakrishna G, Sowjanya P, Laxmi S, Shah KV, Gravitt PE. Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) positivity in cervical cancer screening of women in a peri-urban area in Andhra Pradesh, India. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1373-80. PMID 20447927 DOI: 10.1158/1055-9965.EPI-09-1282  0.369
2010 Averbach SH, Gravitt PE, Nowak RG, Celentano DD, Dunbar MS, Morrison CS, Grimes B, Padian NS. The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe. Aids (London, England). 24: 1035-42. PMID 20397287 DOI: 10.1097/Qad.0B013E3283377973  0.764
2010 Gray RH, Serwadda D, Kong X, Makumbi F, Kigozi G, Gravitt PE, Watya S, Nalugoda F, Ssempijja V, Tobian AA, Kiwanuka N, Moulton LH, Sewankambo NK, Reynolds SJ, Quinn TC, et al. Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda. The Journal of Infectious Diseases. 201: 1455-62. PMID 20370483 DOI: 10.1086/652184  0.601
2010 Serwadda D, Wawer MJ, Makumbi F, Kong X, Kigozi G, Gravitt P, Watya S, Nalugoda F, Ssempijja V, Tobian AA, Kiwanuka N, Moulton LH, Sewankambo NK, Reynolds SJ, Quinn TC, et al. Circumcision of HIV-infected men: effects on high-risk human papillomavirus infections in a randomized trial in Rakai, Uganda. The Journal of Infectious Diseases. 201: 1463-9. PMID 20370481 DOI: 10.1086/652185  0.612
2010 Koshiol J, Wei WQ, Kreimer AR, Ren JS, Gravitt P, Chen W, Kim E, Abnet CC, Zhang Y, Kamangar F, Lin DM, Wang GQ, Roth MJ, Dong ZW, Taylor PR, et al. The gastric cardia is not a target for human papillomavirus-induced carcinogenesis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1137-9. PMID 20332262 DOI: 10.1158/1055-9965.Epi-10-0089  0.635
2010 Marks MA, Gravitt PE, Burk RD, Studentsov Y, Farzadegan H, Klein SL. Progesterone and 17beta-estradiol enhance regulatory responses to human papillomavirus type 16 virus-like particles in peripheral blood mononuclear cells from healthy women. Clinical and Vaccine Immunology : Cvi. 17: 609-17. PMID 20130130 DOI: 10.1128/Cvi.00441-09  0.383
2010 Gravitt PE, Kirk GD. Progress and pitfalls in defining the influence of highly active antiretroviral therapy on human papillomavirus-associated cervical disease. The Journal of Infectious Diseases. 201: 650-2. PMID 20105079 DOI: 10.1086/650468  0.351
2010 Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE. Impact of improved classification on the association of human papillomavirus with cervical precancer. American Journal of Epidemiology. 171: 155-63. PMID 20007673 DOI: 10.1093/Aje/Kwp390  0.718
2010 Taube JM, Kamira B, Motevalli M, Nakabiito C, Lukande R, Kelly DP, Erozan YS, Gravitt PE, Buresh ME, Mmiro F, Bagenda D, Guay LA, Jackson JB. Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low-cost liquid-based Pap preparation. Diagnostic Cytopathology. 38: 555-63. PMID 19937939 DOI: 10.1002/dc.21249  0.597
2010 Gnanamony M, Peedicayil A, Subhashini J, Ram TS, Rajasekar A, Gravitt P, Abraham P. Detection and quantitation of HPV 16 and 18 in plasma of Indian women with cervical cancer. Gynecologic Oncology. 116: 447-51. PMID 19922992 DOI: 10.1016/J.Ygyno.2009.10.081  0.683
2010 Koshiol J, Wei WQ, Kreimer AR, Chen W, Gravitt P, Ren JS, Abnet CC, Wang JB, Kamangar F, Lin DM, von Knebel-Doeberitz M, Zhang Y, Viscidi R, Wang GQ, Gillison ML, et al. No role for human papillomavirus in esophageal squamous cell carcinoma in China. International Journal of Cancer. Journal International Du Cancer. 127: 93-100. PMID 19918949 DOI: 10.1002/Ijc.25023  0.661
2010 Ames A, Gravitt P. Human papillomavirus vaccine update. Current Infectious Disease Reports. 9: 151-8. PMID 17324353 DOI: 10.1007/s11908-007-0011-6  0.366
2009 Gnanamony M, Peedicayil A, Subhashini J, Ram TS, Christopher S, Gravitt P, Abraham P. Human papillomavirus types 16 and 18 mRNA levels and not DNA levels may be associated with advancing stages of cervical cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 19: 1415-20. PMID 20009900 DOI: 10.1111/Igc.0B013E3181B62E05  0.594
2009 Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A, Iyer VK, Mathur SR, Sreenivas V, Shah KV, Gravitt PE. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? Cancer Epidemiology. 33: 446-50. PMID 19931499 DOI: 10.1016/j.canep.2009.10.013  0.543
2009 Andersson S, Sowjanya P, Wangsa D, Hjerpe A, Johansson B, Auer G, Gravitt PE, Larsson C, Wallin KL, Ried T, Heselmeyer-Haddad K. Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears. The American Journal of Pathology. 175: 1831-47. PMID 19880826 DOI: 10.2353/Ajpath.2009.090122  0.445
2009 Adelstein DJ, Ridge JA, Gillison ML, Chaturvedi AK, D'Souza G, Gravitt PE, Westra W, Psyrri A, Kast WM, Koutsky LA, Giuliano A, Krosnick S, Trotti A, Schuller DE, Forastiere A, et al. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head & Neck. 31: 1393-422. PMID 19787782 DOI: 10.1002/Hed.21269  0.423
2009 Althoff KN, Paul P, Burke AE, Viscidi R, Sangaramoorthy M, Gravitt PE. Correlates of cervicovaginal human papillomavirus detection in perimenopausal women. Journal of Women's Health (2002). 18: 1341-6. PMID 19702476 DOI: 10.1089/Jwh.2008.1223  0.539
2009 Wei L, Gravitt PE, Song H, Maldonado AM, Ozbun MA. Nitric oxide induces early viral transcription coincident with increased DNA damage and mutation rates in human papillomavirus-infected cells. Cancer Research. 69: 4878-84. PMID 19487298 DOI: 10.1158/0008-5472.Can-08-4695  0.57
2009 Sowjanya AP, Paul P, Vedantham H, Ramakrishna G, Vidyadhari D, Vijayaraghavan K, Laksmi S, Sudula M, Ronnett BM, Das M, Shah KV, Gravitt PE. Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1373-8. PMID 19423518 DOI: 10.1158/1055-9965.EPI-08-1171  0.517
2009 Wentzensen N, Gravitt PE, Solomon D, Wheeler CM, Castle PE. A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1341-9. PMID 19423515 DOI: 10.1158/1055-9965.Epi-08-1180  0.549
2009 Tobian AA, Serwadda D, Quinn TC, Kigozi G, Gravitt PE, Laeyendecker O, Charvat B, Ssempijja V, Riedesel M, Oliver AE, Nowak RG, Moulton LH, Chen MZ, Reynolds SJ, Wawer MJ, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. The New England Journal of Medicine. 360: 1298-309. PMID 19321868 DOI: 10.1056/Nejmoa0802556  0.715
2009 Yemelyanova A, Vang R, Seidman JD, Gravitt PE, Ronnett BM. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. The American Journal of Surgical Pathology. 33: 914-24. PMID 19295407 DOI: 10.1097/PAS.0b013e3181971fdd  0.413
2009 Phelan DF, Gange SJ, Ahdieh-Grant L, Mehta SH, Kirk GD, Shah K, Gravitt P. Determinants of newly detected human papillomavirus infection in HIV-infected and HIV-uninfected injection drug using women. Sexually Transmitted Diseases. 36: 149-56. PMID 19174735 DOI: 10.1097/Olq.0B013E31818D3Df3  0.549
2009 Trimble CL, Peng S, Kos F, Gravitt P, Viscidi R, Sugar E, Pardoll D, Wu TC. A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 361-7. PMID 19118066 DOI: 10.1158/1078-0432.Ccr-08-1725  0.569
2009 Lin Z, Yemelyanova AV, Gambhira R, Jagu S, Meyers C, Kirnbauer R, Ronnett BM, Gravitt PE, Roden RB. Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2. The American Journal of Pathology. 174: 136-43. PMID 19095951 DOI: 10.2353/Ajpath.2009.080588  0.522
2009 Yu KJ, Hsu WL, Chiang CJ, Cheng YJ, Pfeiffer RM, Diehl SR, Goldstein AM, Gravitt PE, Chen CJ, Hildesheim A. Cancer patterns in nasopharyngeal carcinoma multiplex families in Taiwan. International Journal of Cancer. Journal International Du Cancer. 124: 1622-5. PMID 19065653 DOI: 10.1002/Ijc.24051  0.545
2009 Marks M, Gupta SB, Liaw KL, Kim E, Tadesse A, Coutlee F, Sriplienchan S, Celentano DD, Gravitt PE. Confirmation and quantitation of human papillomavirus type 52 by Roche Linear Array using HPV52-specific TaqMan E6/E7 quantitative real-time PCR. Journal of Virological Methods. 156: 152-6. PMID 19022296 DOI: 10.1016/J.Jviromet.2008.10.013  0.637
2009 Wentzensen N, Gravitt PE, Solomon D, Wheeler CM, Castle PE. A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study (Cancer Epidemiology Biomarkers and Prevention (2009) 18, 1, (1341-9)) Cancer Epidemiology Biomarkers and Prevention. 18: 1943. DOI: 10.1158/1055-9965.Epi-18-6-Cor2  0.314
2009 Nowak R, Gravitt P, Morrison C, Van Der Pol B, Chipato T, Salata R, Kwok C, Munjoma M, Oliver A, Howard R, Gange S, Celentano D. Risk of HPV in Early HIV Infection Among Zimbabwean Women Annals of Epidemiology. 19: 663-664. DOI: 10.1016/J.Annepidem.2009.07.044  0.761
2008 Sankaranarayanan R, Bhatla N, Gravitt PE, Basu P, Esmy PO, Ashrafunnessa KS, Ariyaratne Y, Shah A, Nene BM. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal. Vaccine. 26: M43-52. PMID 18945413 DOI: 10.1016/j.vaccine.2008.05.005  0.546
2008 Ronnett BM, Yemelyanova AV, Vang R, Gilks CB, Miller D, Gravitt PE, Kurman RJ. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms. The American Journal of Surgical Pathology. 32: 1835-53. PMID 18813124 DOI: 10.1097/PAS.0b013e3181758831  0.331
2008 Castle PE, Porras C, Quint WG, Rodriguez AC, Schiffman M, Gravitt PE, González P, Katki HA, Silva S, Freer E, Van Doorn LJ, Jiménez S, Herrero R, Hildesheim A. Comparison of two PCR-based human papillomavirus genotyping methods. Journal of Clinical Microbiology. 46: 3437-45. PMID 18716224 DOI: 10.1128/Jcm.00620-08  0.72
2008 Bhatla N, Dar L, Rajkumar Patro A, Kumar P, Pati SK, Kriplani A, Gulati A, Broor S, Iyer VK, Mathur S, Shah KV, Gravitt PE. Human papillomavirus-type distribution in women with and without cervical neoplasia in north India. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 27: 426-30. PMID 18580322 DOI: 10.1097/PGP.0b013e31816085ba  0.644
2008 Castle PE, Solomon D, Wheeler CM, Gravitt PE, Wacholder S, Schiffman M. Human papillomavirus genotype specificity of hybrid capture 2. Journal of Clinical Microbiology. 46: 2595-604. PMID 18579716 DOI: 10.1128/Jcm.00824-08  0.731
2008 Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Gray R. Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1300-7. PMID 18559545 DOI: 10.1158/1055-9965.Epi-07-2678  0.749
2008 Gravitt PE, Schiffman M, Solomon D, Wheeler CM, Castle PE. A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1248-54. PMID 18483347 DOI: 10.1158/1055-9965.Epi-07-2904  0.654
2008 Hoory T, Monie A, Gravitt P, Wu TC. Molecular epidemiology of human papillomavirus. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 107: 198-217. PMID 18400605 DOI: 10.1016/S0929-6646(08)60138-2  0.627
2008 Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Gray R. Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda. Sexually Transmitted Infections. 84: 306-11. PMID 18385223 DOI: 10.1136/Sti.2007.027318  0.744
2008 Castle PE, Cox JT, Jeronimo J, Solomon D, Wheeler CM, Gravitt PE, Schiffman M. An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS). Obstetrics and Gynecology. 111: 847-56. PMID 18378743 DOI: 10.1097/Aog.0B013E318168460B  0.697
2008 Ferreccio C, Corvalán A, Margozzini P, Viviani P, González C, Aguilera X, Gravitt PE. Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples. Bmc Public Health. 8: 78. PMID 18304362 DOI: 10.1186/1471-2458-8-78  0.341
2008 Wongworapat K, Keawvichit R, Sirirojn B, Dokuta S, Ruangyuttikarn C, Sriplienchan S, Sontirat A, Kla KT, Gravitt PE, Celentano DD. Detection of human papillomavirus from self-collected vaginal samples of women in Chiang Mai, Thailand. Sexually Transmitted Diseases. 35: 172-3. PMID 18216725 DOI: 10.1097/Olq.0B013E318158Af65  0.3
2008 Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. Journal of Clinical Microbiology. 46: 109-17. PMID 17989194 DOI: 10.1128/Jcm.01667-07  0.726
2008 Trimble CL, Gravitt P, Roden RBS. Human papillomavirus screening and vaccines for cancer prevention: What is on the horizon? Therapy. 5: 295-303. DOI: 10.2217/14750708.5.3.295  0.555
2008 Trimble C, Thoburn C, Kos F, Peng S, Viscidi R, Gravitt P, Roden R, Wu T, Pardoll D, Sugar E, Jungbluth A. Su.98. Mechanisms of Immune Privilege in High Grade Cervical Dysplasia Clinical Immunology. 127: S156. DOI: 10.1016/J.Clim.2008.03.449  0.307
2008 Trimble C, Peng S, Roden R, Gravitt P, Pardoll D, Sugar E, Thoburn C, Wu T. OR.52. Phase I Evaluation of Therapeutic, E7-targeted DNA Vaccination in Women with HPV16+ High Grade Cervical Dysplasia (CIN2/3) Clinical Immunology. 127: S22. DOI: 10.1016/J.Clim.2008.03.058  0.594
2007 Gravitt PE, Kovacic MB, Herrero R, Schiffman M, Bratti C, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Rodriguez AC, Burk RD. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease International Journal of Cancer. 121: 2787-2793. PMID 17722112 DOI: 10.1002/Ijc.23012  0.699
2007 Gambhira R, Jagu S, Karanam B, Gravitt PE, Culp TD, Christensen ND, Roden RB. Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2. Journal of Virology. 81: 11585-92. PMID 17715230 DOI: 10.1128/JVI.01577-07  0.441
2007 Gravitt PE, van Doorn LJ, Quint W, Schiffman M, Hildesheim A, Glass AG, Rush BB, Hellman J, Sherman ME, Burk RD, Wang SS. Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions. Journal of Clinical Microbiology. 45: 3245-50. PMID 17699644 DOI: 10.1128/Jcm.00216-07  0.713
2007 Safaeian M, Kiddugavu M, Gravitt PE, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Gray R. Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda. Sexually Transmitted Diseases. 34: 429-36. PMID 17075437 DOI: 10.1097/01.Olq.0000243623.67673.22  0.767
2007 Ames A, Gravitt P. Human papillomavirus vaccine update Current Infectious Disease Reports. 9: 151-158. DOI: 10.1007/S11908-007-0011-6  0.458
2006 Gambhira R, Gravitt PE, Bossis I, Stern PL, Viscidi RP, Roden RB. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species. Cancer Research. 66: 11120-4. PMID 17145854 DOI: 10.1158/0008-5472.CAN-06-2560  0.499
2006 Bhatla N, Dar L, Patro AR, Kriplani A, Gulati A, Verma K, Broor S, Shah KV, Gravitt PE. Human papillomavirus type distribution in cervical cancer in Delhi, India. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 25: 398-402. PMID 16990719 DOI: 10.1097/01.pgp.0000209574.62081.e4  0.613
2006 Peedicayil A, Abraham P, Sathish N, John S, Shah K, Sridharan G, Gravitt P. Human papillomavirus genotypes associated with cervical neoplasia in India International Journal of Gynecological Cancer. 16: 1591-1595. PMID 16884371 DOI: 10.1111/J.1525-1438.2006.00631.X  0.691
2005 Sowjanya AP, Jain M, Poli UR, Padma S, Das M, Shah KV, Rao BN, Devi RR, Gravitt PE, Ramakrishna G. Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. Bmc Infectious Diseases. 5: 116. PMID 16371167 DOI: 10.1186/1471-2334-5-116  0.604
2005 D'Souza G, Sugar E, Ruby W, Gravitt P, Gillison M. Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR. Journal of Clinical Microbiology. 43: 5526-35. PMID 16272481 DOI: 10.1128/Jcm.43.11.5526-5535.2005  0.753
2005 Fontaine J, Gravitt P, Duh LM, Lefevre J, Pourreaux K, Hankins C, Coutlée F. High level of correlation of human papillomavirus-16 DNA viral load estimates generated by three real-time PCR assays applied on genital specimens. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 2200-7. PMID 16172232 DOI: 10.1158/1055-9965.Epi-05-0055  0.679
2005 Trimble CL, Piantadosi S, Gravitt P, Ronnett B, Pizer E, Elko A, Wilgus B, Yutzy W, Daniel R, Shah K, Peng S, Hung C, Roden R, Wu TC, Pardoll D. Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4717-23. PMID 16000566 DOI: 10.1158/1078-0432.Ccr-04-2599  0.617
2005 Gravitt PE, Jamshidi R. Diagnosis and management of oncogenic cervical human papillomavirus infection Infectious Disease Clinics of North America. 19: 439-458. PMID 15963882 DOI: 10.1016/j.idc.2005.03.008  0.568
2005 Zelmanowicz Ade M, Schiffman M, Herrero R, Goldstein AM, Sherman ME, Burk RD, Gravitt P, Viscidi R, Schwartz P, Barnes W, Mortel R, Silverberg SG, Buckland J, Hildesheim A. Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States. International Journal of Cancer. Journal International Du Cancer. 116: 599-605. PMID 15818615 DOI: 10.1002/Ijc.21048  0.676
2005 Gravitt PE, Shah KV. A Virus-based Vaccine May Prevent Cervical Cancer. Current Infectious Disease Reports. 7: 125-131. PMID 15727740  0.566
2004 Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, Garrett ES, Shah KV, Gillison ML. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. The Journal of Infectious Diseases. 189: 686-98. PMID 14767823 DOI: 10.1086/381504  0.606
2003 Burk RD, Terai M, Gravitt PE, Brinton LA, Kurman RJ, Barnes WA, Greenberg MD, Hadjimichael OC, Fu L, McGowan L, Mortel R, Schwartz PE, Hildesheim A. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Research. 63: 7215-20. PMID 14612516  0.601
2003 Sherman ME, Wang SS, Wheeler CM, Rich L, Gravitt PE, Tarone R, Schiffman M. Determinants of Human Papillomavirus Load among Women with Histological Cervical Intraepithelial Neoplasia 3: Dominant Impact of Surrounding Low-Grade Lesions Cancer Epidemiology Biomarkers and Prevention. 12: 1038-1044. PMID 14578140  0.706
2003 Gravitt PE, Peyton C, Wheeler C, Apple R, Higuchi R, Shah KV. Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. Journal of Virological Methods. 112: 23-33. PMID 12951209 DOI: 10.1016/S0166-0934(03)00186-1  0.607
2003 Gravitt PE, Burk RD, Lorincz A, Herrero R, Hildesheim A, Sherman ME, Bratti MC, Rodriguez AC, Helzlsouer KJ, Schiffman M. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 477-84. PMID 12814990  0.642
2003 Gravitt PE, Hildesheim A, Herrero R, Schiffman M, Sherman ME, Bratti MC, Rodriguez AC, Morera LA, Cardenas F, Bowman FP, Shah KV, Crowley-Nowick PA. Correlates of IL-10 and IL-12 concentrations in cervical secretions. Journal of Clinical Immunology. 23: 175-83. PMID 12797539 DOI: 10.1023/A:1023305827971  0.511
2003 Altekruse SF, Lacey JV, Brinton LA, Gravitt PE, Silverberg SG, Barnes WA, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Hildesheim A. Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. American Journal of Obstetrics and Gynecology. 188: 657-63. PMID 12634637 DOI: 10.1067/mob.2003.132  0.398
2002 Castle PE, Schiffman M, Gravitt PE, Kendall H, Fishman S, Dong H, Hildesheim A, Herrero R, Concepcion Bratti M, Sherman ME, Lorincz A, Schussler JE, Burk RD. Comparisons of HPV DNA detection by MY09/11 PCR methods Journal of Medical Virology. 68: 417-423. PMID 12226831 DOI: 10.1002/Jmv.10220  0.706
2002 Gravitt PE, Kamath AM, Gaffikin L, Chirenje ZM, Womack S, Shah KV. Human papillomavirus genotype prevalence in high-grade squamous intraepithelial lesions and colposcopically normal women from Zimbabwe. International Journal of Cancer. Journal International Du Cancer. 100: 729-32. PMID 12209615 DOI: 10.1002/ijc.10538  0.364
2002 Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, Rush BB, Gravitt PE, Schussler JE, Schiffman M. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet. 360: 228-9. PMID 12133661 DOI: 10.1016/S0140-6736(02)09463-1  0.69
2002 Coutlée F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples Journal of Clinical Microbiology. 40: 902-907. PMID 11880413 DOI: 10.1128/Jcm.40.3.902-907.2002  0.644
2001 Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ, Wheeler CM. Determinants of genital human papillomavirus detection in a US population Journal of Infectious Diseases. 183: 1554-1564. PMID 11343204 DOI: 10.1086/320696  0.612
2001 Gravitt PE, Castle PE, Smith JS, Muñoz N, Franceschi S, Eluf-Neto J, Herrero R, Peeling RW, Morré SA, Ossewaarde JM, Numazaki K, Ikehata M, Chiba S, Anttila T, Koskela P, et al. Chlamydia trachomatis and cervical squamous cell carcinoma [3] (multiple letters) Journal of the American Medical Association. 285: 1703-1706. PMID 11277819  0.31
2001 Lacey JV, Frisch M, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Zaino RJ, Hildesheim A. Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes & Control : Ccc. 12: 153-61. PMID 11246844 DOI: 10.1023/A:1008918310055  0.458
2001 Gravitt PE, Lacey JV, Brinton LA, Barnes WA, Kornegay JR, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Zaino R, Hildesheim A. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 10: 95-100. PMID 11219778  0.57
2001 Liaw KL, Hildesheim A, Burk RD, Gravitt P, Wacholder S, Manos MM, Scott DR, Sherman ME, Kurman RJ, Glass AG, Anderson SM, Schiffman M. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types Journal of Infectious Diseases. 183: 8-15. PMID 11087198 DOI: 10.1086/317638  0.762
2000 Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. Improved amplification of genital human papillomaviruses Journal of Clinical Microbiology. 38: 357-361. PMID 10618116 DOI: 10.1128/Jcm.38.1.357-361.2000  0.583
1999 Lacey JV, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Silverberg SG, Hildesheim A. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 8: 1079-85. PMID 10613340  0.501
1999 Coutlée F, Gravitt P, Richardson H, Hankins C, Franco E, Lapointe N, Voyer H, Gill J, Romanowski B, Shafran S, Grimshaw R, Haase D, Schlech W, Landis S, Sellors J, et al. Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay Journal of Clinical Microbiology. 37: 1852-1857. PMID 10325336 DOI: 10.1128/Jcm.37.6.1852-1857.1999  0.547
1998 Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method Journal of Clinical Microbiology. 36: 3020-3027. PMID 9738060 DOI: 10.1128/Jcm.36.10.3020-3027.1998  0.578
1995 Stewart ACM, Gravitt PE, Cheng Z, Wheeler CM. Generation of entire human papillomavirus genomes by long PCR: Frequency of errors produced during amplification Genome Research. 5: 79-88. PMID 8717058 DOI: 10.1101/Gr.5.1.79  0.481
1994 Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME. Persistence of type-specific human papillomavirus infection among cytologically normal women. The Journal of Infectious Diseases. 169: 235-40. PMID 8106758 DOI: 10.1093/infdis/169.2.235  0.739
1993 Kuypers JM, Critchlow CW, Gravitt PE, Vernon DA, Sayer JB, Manos MM, Kiviat NB. Comparison of dot filter hybridization, southern transfer hybridization, and polymerase chain reaction amplification for diagnosis of anal human papillomavirus infection Journal of Clinical Microbiology. 31: 1003-1006. PMID 8385147 DOI: 10.1128/Jcm.31.4.1003-1006.1993  0.522
1993 Hildesheim A, Gravitt P, Schiffman MH, Kurman RJ, Barnes W, Jones S, Tchabo JG, Brinton LA, Copeland C, Epp J, Manos MM. Determinants of genital human papillomavirus infection in low-income women in washington, D.C Sexually Transmitted Diseases. 20: 279-285. PMID 8235926 DOI: 10.1097/00007435-199309000-00008  0.757
1992 Gravitt PE, Manos MM. Polymerase chain reaction-based methods for the detection of human papillomavirus DNA Iarc Scientific Publications. 121-133. PMID 1330905  0.505
1992 Kemp EA, Hakenewerth AM, Laurent SL, Gravitt PE, Stoerker J. Human papillomavirus prevalence in pregnancy Obstetrics and Gynecology. 79: 649-656. PMID 1314358  0.582
1991 Gravitt P, Hakenewerth A, Stoerker J. A direct comparison of methods proposed for use in widespread screening of human papillomavirus infections Molecular and Cellular Probes. 5: 65-72. PMID 1850116 DOI: 10.1016/0890-8508(91)90039-M  0.673
Show low-probability matches.